Disciplined Investments’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5
Closed -$457 178
2023
Q2
$457 Buy
5
+3
+150% +$246 ﹤0.01% 1262
2023
Q1
$147 Sell
2
-3
-60% -$260 ﹤0.01% 1534
2022
Q4
$418 Sell
5
-1
-17% -$90 ﹤0.01% 1245
2022
Q3
$1K Buy
6
+4
+200% +$477 ﹤0.01% 772
2022
Q2
$0 Sell
2
-3
-60% -$383 ﹤0.01% 1241
2022
Q1
$1K Buy
+5
New +$747 ﹤0.01% 852

Other funds holding AMED

Disciplined Investments's AMED Position: Q3 2023 in Review

Disciplined Investments sold out of Amedisys (AMED) in Q3 2023, closing a stake of 5 shares — an estimated $457 sold.

Disciplined Investments first reported a position in AMED in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q3 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.

  • Disciplined Investments reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 5 Amedisys shares in Q3 2023, an estimated $457.
  • Disciplined Investments first reported a position in Amedisys in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Amedisys position peaked at $1K in Q3 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.